The primary mission of Normandy Hadrontherapy is the design, development, manufacturing, installation, industrialisation and subsequent commercialisation of a first hadrontherapy research and treatment system based on cyclotron technology.
Hadrontherapy is a form of radiotherapy that uses beams of accelerated protons and ions to treat radio-resistant tumours.
Hadrontherapy is a form of radiotherapy that uses beams of accelerated protons and ions (helium, carbon) to treat complex and radio-resistant tumours.
To improve the destruction of cancer cells while minimising damage to the patient’s healthy tissue and organs not yet affected by the tumour. Hadrontherapy is used to treat radio-resistant and/or inoperable cancers at a still relatively localised stage of progression. It can therefore be relevant for a large number of patients.
Discover the different types of cancers for which this technology may be a viable therapeutic option.
In Caen, our first centre being equipped with the C400 IONS is taking shape within CYCLHAD, a hadrontherapy treatment and research centre, in partnership with the Centre François Baclesse.
For this centre, we are delivering a multi-particle installation (proton, helium, carbon) comprising three rooms with fixed horizontal beamlines, one of which is dedicated to fundamental physics research.
Because moving in the right direction means surrounding yourself with the best, many stakeholders work every day to carry this project forward.
Normandy Hadrontherapy is looking for new talent to grow its team and successfully carry out its activities.
Enter your details to receive the brochure by email.
